Ocumension Therapeutics (HKSE:01477) Beginning Cash Position : HK$587.4 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Ocumension Therapeutics Beginning Cash Position?

Ocumension Therapeutics's Beginning Cash Position for the quarter that ended in Dec. 2023 was HK$587.4 Mil.

Ocumension Therapeutics's quarterly Beginning Cash Position declined from Dec. 2022 (HK$1,755.8 Mil) to Jun. 2023 (HK$1,279.8 Mil) and declined from Jun. 2023 (HK$1,279.8 Mil) to Dec. 2023 (HK$587.4 Mil).

Ocumension Therapeutics's annual Beginning Cash Position declined from Dec. 2021 (HK$2,491.0 Mil) to Dec. 2022 (HK$1,256.6 Mil) but then increased from Dec. 2022 (HK$1,256.6 Mil) to Dec. 2023 (HK$1,279.8 Mil).

Ocumension Therapeutics Beginning Cash Position Historical Data

The historical data trend for Ocumension Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocumension Therapeutics Beginning Cash Position Chart

Ocumension Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

28.52

228.08

2,490.96

1,256.55

1,279.78

Ocumension Therapeutics Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial						2,766.18	1,318.98	1,755.80	1,279.78	587.41

Ocumension Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Ocumension Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Ocumension Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocumension Therapeutics (HKSE:01477) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocumension Therapeutics (HKSE:01477) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

5DG:Germany

Address

No. 1858 Yinzhongnan Road, Guoxiang Subdistrict, Wuzhong District, Suzhou, Jiangsu, CHN

Website

http://www.ocumension.com

Ocumension Therapeutics is an ophthalmic pharmaceutical platform company identifying, developing, and commercializing ophthalmic therapies. It provides a pharmaceutical total solution to address unmet ophthalmic medical needs in China. Its product candidates include OT-401 (YUTIQ), OT-101, OT-301 (NCX 470), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-202, OT-503 (NCX 4251), OT-701, Ou Qin, Brimonidine tartrate eye drop, 0.5% moxifloxacin eye drop, OT-601-C, OT-302, OT-1301, T-1601, and OT-1602.

Ocumension Therapeutics (HKSE:01477) Headlines

No Headlines